Physician profile
David A Kyle
NPI 1518212026
$9,122.14
in general payments reported to CMS, 2019-2025
25 companies · $5,130 in 2025
The $5,130 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $271 · 2020: $186 · 2021: $286 · 2022: $612 · 2023: $1,053 · 2024: $1,583 · 2025: $5,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,598 · Consulting Fee: $3,000 · Travel and Lodging: $168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,598.38 |
| Consulting Fee | $3,000.00 |
| Travel and Lodging | $168.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $3,684.34 | 2022-2025 | |
| Stryker Corporation | $3,547.33 | 2019-2025 | Ortholoc 2 Lapifuse, N/A, Variax |
| Smith+Nephew, INC. | $472.10 | 2020-2025 | Stravix, Renasys Go V2 Home, Footprint |
| Depuy Synthes Sales INC. | $270.09 | 2021-2025 | Motoband, Va-Lcp, Na |
| Surgenex LLC | $160.12 | 2025 | Pellograft, Surmatrix, Surgraft |
| Bioventus LLC | $144.78 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Horizon Therapeutics Plc | $124.71 | 2019-2021 | |
| Abbvie INC. | $124.09 | 2022-2025 | |
| Mimedx Group, INC. | $93.31 | 2024-2025 | |
| Acera Surgical, INC. | $56.43 | 2020 | |
| Integra Lifesciences Corporation | $54.90 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kci USA, INC. | $49.22 | 2021-2023 | Activ.A.C. Ion Progress, Activ.A.C., Promogran Prisma |
| Pacira Pharmaceuticals Incorporated | $48.21 | 2023-2024 | Exparel, Iovera, Zilretta |
| Kerecis Limited | $43.89 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Kowa Pharmaceuticals America, INC. | $43.51 | 2022-2023 | Seglentis, Livalo |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $33.02 | 2023 | |
| Abbott Laboratories | $26.48 | 2022 | |
| Linvatec Corporation | $21.86 | 2025 | Quantum |
| Biocomposites INC | $21.63 | 2025 | Stimulan |
| Organogenesis INC. | $21.30 | 2022 | |
| Averitas Pharma INC. | $19.43 | 2023 | Qutenza |
| Wound Management Technologies, INC | $17.93 | 2019 | |
| Zyla Life Sciences, INC. | $15.43 | 2020 | |
| Convatec INC. | $15.22 | 2023 | |
| Misonix INC | $12.81 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.